It has also been reported that the up-regulation of RCN2 can activate the MYC signal and regulate the activation of the EGFR-ERK pathway to promote the occurrence of hepatocellular carcinoma (HCC)43. The gene discussed is MYC; the disease is hepatocellular carcinoma.